Activation of bioluminescence by structural complementation

1. A polypeptide comprising an amino acid sequence having greater than 40% but not greater than 95% sequence identity with SEQ ID NO: 440, wherein a bioluminescent signal produced in the presence of a furimazine substrate is substantially increased when the polypeptide contacts a peptide consisting of SEQ ID NO: 2 when compared to a bioluminescent signal produced by the polypeptide and furimazine substrate alone, and wherein the amino acid sequence is not a naturally occurring protein or a fragment thereof.

2. The polypeptide of claim 1 , wherein the polypeptide exhibits enhancement of one or more traits compared to a polypeptide of SEQ ID NO: 440, wherein the traits are selected from: affinity for the peptide consisting of SEQ ID NO: 2, expression, intracellular solubility, intracellular stability, and bioluminescent activity when combined with the peptide consisting of SEQ ID NO: 2.

3. The polypeptide of claim 1 , wherein the amino acid sequence is selected from one of the polypeptide sequences of Table 2.

4. The polypeptide of claim 1 , wherein the amino acid sequence is synthetic, contains non-natural amino acids or is a peptide mimic.

5. A fusion polypeptide comprising the polypeptide of claim 1 and a first interaction polypeptide that is configured to form a complex with a second interaction polypeptide upon contact of the first interaction polypeptide and the second interaction polypeptide.

6. A bioluminescent complex comprising:

(a) the fusion polypeptide of claim 5 ; and

(b) a second fusion polypeptide comprising:

i) the second interaction polypeptide, and

ii) a complement peptide that emits a detectable bioluminescent signal in the presence of a substrate when associated with a polypeptide comprising an amino acid sequence having less than 100% and greater than 40% sequence identity with SEQ ID NO: 440;

wherein the fusion polypeptide of claim 5 and the second fusion polypeptide are associated;

and wherein the polypeptide comprising an amino acid sequence having greater than 40% but not greater than 95% sequence identity with SEQ ID NO: 440 and the complement peptide are associated.

7. A bioluminescent complex comprising a non-covalent association of:

(a) a peptide comprising a peptide amino acid sequence having less than 100% and greater than 40% sequence identity with SEQ ID NO: 2, wherein the peptide is not a naturally occurring protein or a fragment thereof; and

(b) a polypeptide comprising a polypeptide amino acid sequence having greater than 40% but not greater than 95% sequence identity with SEQ ID NO: 440, wherein the polypeptide is not a naturally occurring protein or a fragment thereof, wherein the bioluminescent complex exhibits detectable luminescence;

wherein the bioluminescent complex produces substantially increased luminescence in the presence of a furimazine substrate when compared to either the peptide or polypeptide alone in the presence of the furimazine substrate.

8. The bioluminescent complex of claim 7 , wherein the peptide amino acid sequence is selected from the peptide sequences of Table 1.

9. The bioluminescent complex of claim 7 , wherein the polypeptide amino acid sequence is selected from the polypeptide sequences of Table 2.

10. The bioluminescent complex of claim 7 , wherein the peptide amino acid sequence is attached to a first interaction element that is associated with a second interaction element.

11. The bioluminescent complex of claim 10 , wherein the polypeptide amino acid sequence is attached to the second interaction element.

12. The bioluminescent complex of claim 11 , wherein the polypeptide amino acid sequence and peptide amino acid sequence are substantially non-luminescent in the absence of the association of the first and second interaction elements.